197 related articles for article (PubMed ID: 34478834)
1. Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.
Buehler PW; Swindle D; Pak DI; Ferguson SK; Majka SM; Karoor V; Moldovan R; Sintas C; Black J; Gentinetta T; Buzzi RM; Vallelian F; Wassmer A; Edler M; Bain J; Schu D; Hassell K; Nuss R; Schaer DJ; Irwin DC
Free Radic Biol Med; 2021 Nov; 175():95-107. PubMed ID: 34478834
[TBL] [Abstract][Full Text] [Related]
2. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
Yalamanoglu A; Deuel JW; Hunt RC; Baek JH; Hassell K; Redinius K; Irwin DC; Schaer DJ; Buehler PW
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L765-L774. PubMed ID: 30047285
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
[TBL] [Abstract][Full Text] [Related]
4. Double-edged functions of hemopexin in hematological related diseases: from basic mechanisms to clinical application.
Li Y; Chen R; Wang C; Deng J; Luo S
Front Immunol; 2023; 14():1274333. PubMed ID: 38022615
[TBL] [Abstract][Full Text] [Related]
5. Chlorine inhalation induces acute chest syndrome in humanized sickle cell mouse model and ameliorated by postexposure hemopexin.
Alishlash AS; Sapkota M; Ahmad I; Maclin K; Ahmed NA; Molyvdas A; Doran S; Albert CJ; Aggarwal S; Ford DA; Ambalavanan N; Jilling T; Matalon S
Redox Biol; 2021 Aug; 44():102009. PubMed ID: 34044323
[TBL] [Abstract][Full Text] [Related]
6. Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia.
Ferguson SK; Redinius K; Yalamanoglu A; Harral JW; Hyen Baek J; Pak D; Loomis Z; Hassell D; Eigenberger P; Nozik-Grayck E; Nuss R; Hassell K; Stenmark KR; Buehler PW; Irwin DC
J Physiol; 2019 Feb; 597(4):1073-1085. PubMed ID: 29931797
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
[TBL] [Abstract][Full Text] [Related]
8. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.
Smith A; McCulloh RJ
Front Physiol; 2015; 6():187. PubMed ID: 26175690
[TBL] [Abstract][Full Text] [Related]
9. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
[TBL] [Abstract][Full Text] [Related]
10. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
11. Hemopexin increases the neurotoxicity of hemoglobin when haptoglobin is absent.
Chen-Roetling J; Ma SK; Cao Y; Shah A; Regan RF
J Neurochem; 2018 Jun; 145(6):464-473. PubMed ID: 29500821
[TBL] [Abstract][Full Text] [Related]
12. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
13. Original Research: Diametric effects of hypoxia on pathophysiology of sickle cell disease in a murine model.
Tan F; Ghosh S; Mosunjac M; Manci E; Ofori-Acquah SF
Exp Biol Med (Maywood); 2016 Apr; 241(7):766-71. PubMed ID: 27026725
[TBL] [Abstract][Full Text] [Related]
14. Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice.
Yalamanoglu A; Dubach IL; Schulthess N; Ingoglia G; Swindle DC; Humar R; Schaer DJ; Buehler PW; Irwin DC; Vallelian F
Front Immunol; 2021; 12():627944. PubMed ID: 33763072
[TBL] [Abstract][Full Text] [Related]
15. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU
Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351
[TBL] [Abstract][Full Text] [Related]
16. Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.
Ashouri R; Fangman M; Burris A; Ezenwa MO; Wilkie DJ; Doré S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203861
[TBL] [Abstract][Full Text] [Related]
17. Human Plasma and Recombinant Hemopexins: Heme Binding Revisited.
Karnaukhova E; Owczarek C; Schmidt P; Schaer DJ; Buehler PW
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530421
[TBL] [Abstract][Full Text] [Related]
18. Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease.
Vendrame F; Olops L; Saad STO; Costa FF; Fertrin KY
J Clin Lipidol; 2018; 12(6):1532-1538. PubMed ID: 30219641
[TBL] [Abstract][Full Text] [Related]
19. Heme-hemopexin complex attenuates neuronal cell death and stroke damage.
Li RC; Saleem S; Zhen G; Cao W; Zhuang H; Lee J; Smith A; Altruda F; Tolosano E; Doré S
J Cereb Blood Flow Metab; 2009 May; 29(5):953-64. PubMed ID: 19277051
[TBL] [Abstract][Full Text] [Related]
20. Hemopexin deficiency promotes acute kidney injury in sickle cell disease.
Ofori-Acquah SF; Hazra R; Orikogbo OO; Crosby D; Flage B; Ackah EB; Lenhart D; Tan RJ; Vitturi DA; Paintsil V; Owusu-Dabo E; Ghosh S;
Blood; 2020 Mar; 135(13):1044-1048. PubMed ID: 32043112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
